Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update

Executive Summary

• Red Light Holland reported unaudited Q3 2026 results, showing revenue of C$1.265 M (+8.3% YoY) and a cash balance of C$9.238 M.
• Adjusted EBITDA loss widened to C$0.711 M (up 4.5% from the prior year), while G&A expenses fell 15.8% to C$1.199 M.
• The company disclosed several operational updates, including a second 5 kg psilocybin shipment to partner Irvine Labs, cessation of shiitake mushroom production at its New Brunswick farm, and ongoing M&A discussions.

Key Details

• Cash Position: End‑quarter cash C$9.238 M (down from C$10.226 M three months earlier).
• Net Cash Use: C$0.989 M net outflow for the quarter (increase of C$1.493 M vs Q3 2025).
• Revenue: C$1.265 M for Q3 2026, up 8.3% YoY.
• Gross Profit: C$0.358 M (down 13.7% YoY).
• G&A Expenses: C$1.199 M, down 15.8% YoY due to lower consulting, management, legal and professional fees.
• Adjusted EBITDA Loss: C$0.711 M, a 4.5% increase in loss versus the same quarter last year.
• Total Assets: C$18.200 M (down from C$19.018 M).

R&D & Partnerships

• Irvine Labs received a second 5 kg shipment of natural psilocybin (Nov 2025), supporting expanded dehydration and packaging validation; product condition issues noted.
• Ongoing discussions with Irvine Labs on commercial micro‑dosing capsule manufacturing for therapeutic markets.
• Collaboration with Arizona State University’s Psychedelic Genome Project to study genetic influences on psilocybin response.

Commercial Operations

• SR Wholesale (Netherlands): Continued growth, serving >125 retail stores despite slower tourism.
• Albertsons Partnership: Expanded U.S. retail presence under Safeway banner; further talks ongoing.
• Functional Mushroom Gummies: Health Canada‑approved product launched on Amazon, later removed; stability testing completed successfully.
• Pilot with Real Canadian Superstore (RCSS): Launched gummies but no additional store rollout during the quarter.

Asset & Business Adjustments

• Shut down shiitake mushroom production at AEM Farm (New Brunswick); assets (trolleys, tractor, mixer) being sold to repay creditors.
• Advanced talks to sell 100 % of rights to farmland, plans and permits in Peterborough, Ontario for an estimated C$2.5‑2.6 M; no definitive agreement yet.

M&A Activity

• Management actively evaluating strategic acquisition opportunities to bolster R&D focus; no commitments disclosed.

Notable Quotes

“We were encouraged to see sales return to normalized levels…most importantly, we continue to actively evaluate strategic M&A opportunities from a position of strength.” – Todd Shapiro, CEO & Director

“As we evolve into an R&D‑driven organization supported by a solid balance sheet, inbound interest for collaboration and capital is increasing, reinforcing our credibility in the sector.” – Todd Shapiro